ILIU

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 1/24/2017
Contact Info
  • 135 Beaver Street
  • Waltham, MA 02452

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2017 10-Q
CIK 0001037649
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2835 - Diagnostic substances
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Mark B. Carbeau CEO
Stephen DiPalma Interim CFO
Company Directors
James M. Weaver Chairman
Mark B. Carbeau
Lionel Carrot
William C Mills III
Joseph M. Landstra
Dayton Misfeldt
Service Providers
Accounting/Auditing Firm
Grant Thornton LLP
226 Causeway Street
Boston, MA, 02114
United States
 
Securities Counsel
Mintz, Levin, Cohen, Ferris, Glovsky and Popeo, P.C.
One Financial Center
Boston, MA, 02111
United States
 
Investor Relations Firm

Not Available
Company History
  • Note=3-00 State of Incorporation Texas changed to Delaware
  • Formerly=Medical Science Systems, Inc. until 8-99
ILIU Security Details
Share Structure
Market Value1 $14,732,063 a/o May 24, 2017
Authorized Shares 650,000,000 a/o Oct 20, 2016
Outstanding Shares 229,471,392 a/o Apr 13, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 40,865,161 a/o Mar 27, 2016
Par Value 0.001
Shareholders
Shareholders of Record 121 a/o Apr 17, 2017
Short Selling Data
Short Interest 2,276 (-11.65%)
Apr 28, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security